Overview

Avastin for Post-Photocoagulation Macular Edema

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

to evaluate the efficacy of a single intravitreal bevacizumab (IVB) injection, 0.1mL (2.5mg), against panretinal photocoagulation (PRP)-induced macular thickening and visual disturbance in patients with severe nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) and good vision

Phase:

Phase 4

Details

Lead Sponsor:

Asociación para Evitar la Ceguera en México

Treatments:

Bevacizumab